Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Palatin Technologies, Inc. - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
PTN
American
8731
https://www.palatin.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Palatin Technologies, Inc.
Palatin Announces Results of PL9643 MELODY-1 Pivotal Phase 3 Clinical Trial in Patients with Dry Eye Disease (DED)
- Feb 28th, 2024 12:30 pm
Palatin Technologies, Inc. (AMEX:PTN) Q2 2024 Earnings Call Transcript
- Feb 16th, 2024 3:00 pm
Q2 2024 Palatin Technologies Inc Earnings Call
- Feb 16th, 2024 5:55 am
Palatin Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
- Feb 15th, 2024 12:30 pm
Palatin to Report Second Quarter Fiscal Year 2024 Results; Teleconference and Webcast to be held on February 15, 2024
- Feb 9th, 2024 12:30 pm
Palatin Announces Database Lock for PL9643 MELODY-1 Pivotal Phase 3 Clinical Trial in Patients with Dry Eye Disease (DED)
- Feb 5th, 2024 12:30 pm
Palatin Announces Closing of $10 Million Registered Direct Offering
- Feb 1st, 2024 9:00 pm
Palatin Announces $10 Million Registered Direct Offering
- Jan 30th, 2024 1:00 pm
Strength Seen in Repligen (RGEN): Can Its 4.3% Jump Turn into More Strength?
- Jan 29th, 2024 10:09 am
3 Penny Stocks to Buy to Unlock 2,500% Upside Potential
- Jan 11th, 2024 6:38 pm
Palatin Provides Corporate Update and Highlights Strategic Priorities for Calendar Year 2024
- Jan 8th, 2024 3:33 pm
Cosette Pharmaceuticals Acquires Vyleesi® (Bremelanotide Injection) from Palatin Technologies Inc.
- Jan 3rd, 2024 1:00 pm
Analysts Say 3 Stocks Have a Combined Upside of 3000%
- Dec 23rd, 2023 10:00 pm
Palatin Completes Sale of Vyleesi® to Cosette Pharmaceuticals for up to $171 Million
- Dec 20th, 2023 12:30 pm
Palatin Receives Notice of Acceptance of the Listing Standards Compliance Plan from NYSE American
- Dec 18th, 2023 9:15 pm
Palatin Technologies, Inc. (AMEX:PTN) Q1 2024 Earnings Call Transcript
- Nov 15th, 2023 8:01 pm
Q1 2024 Palatin Technologies Inc Earnings Call
- Nov 15th, 2023 8:29 am
Palatin Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
- Nov 14th, 2023 12:30 pm
Kronos Bio, Inc. (KRON) Reports Q3 Loss, Lags Revenue Estimates
- Nov 13th, 2023 10:25 pm
Palatin to Report First Quarter Fiscal Year 2024 Results; Teleconference and Webcast to be held on November 14, 2023
- Nov 9th, 2023 12:30 pm
Scroll